Principal Financial Group’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.47M Sell
75,200
-100,730
-57% -$2.99M ﹤0.01% 1871
2025
Q4
$5.47M Sell
175,930
-37,399
-18% -$1.03M ﹤0.01% 1585
2025
Q3
$4.6M Buy
213,329
+9,493
+5% +$171K ﹤0.01% 1618
2025
Q2
$2.85M Sell
203,836
-5,000
-2% -$67.9K ﹤0.01% 1734
2025
Q1
$2.82M Buy
208,836
+30,392
+17% +$518K ﹤0.01% 1704
2024
Q4
$3.42M Buy
178,444
+5,634
+3% +$123K ﹤0.01% 1692
2024
Q3
$3.93M Buy
172,810
+162,665
+1,603% +$2.66M ﹤0.01% 1634
2024
Q2
$132K Sell
10,145
-1,770
-15% -$24.5K ﹤0.01% 2198
2024
Q1
$209K Buy
11,915
+1,058
+10% +$20.5K ﹤0.01% 2169
2023
Q4
$236K Sell
10,857
-199
-2% -$3.14K ﹤0.01% 2120
2023
Q3
$170K Buy
11,056
+222
+2% +$4.24K ﹤0.01% 2192
2023
Q2
$258K Buy
10,834
+819
+8% +$21K ﹤0.01% 2116
2023
Q1
$255K Sell
10,015
-114
-1% -$3.65K ﹤0.01% 2127
2022
Q4
$296K Buy
+10,129
New +$233K ﹤0.01% 2102

Other funds holding VRDN